Vanda Pharmaceuticals(VNDA) - 2025 Q4 - Annual Results

Exhibit 99.1 Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results WASHINGTON – February 11, 2026 – Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended December 31, 2025. "2025 showed strong momentum at Vanda, led by Fanapt, with net product sales up 24% to $117.3 million, driven by a 28% rise in total prescriptions and 149% surge in new-to-brand prescriptions - reflecting accelerating grow ...